Joniau S., Spahn M., Briganti A., Gandaglia G., Tombal B., Tosco L., Marchioro G., Hsu C.-Y., Walz J., Kneitz B., Bader P., Frohneberg D., Tizzani A., Graefen M., van Cangh P., Karnes R.J., Montorsi F., van Poppel H., Gontero P.
European Urology 2014
Background: Pretreatment tables for the prediction of pathologic stage have been published and validated for localized prostate cancer (PCa). No such tables are available for locally advanced (cT3a) PCa. Objective: To construct tables predicting pathologic outcome after radical prostatectomy (RP) for patients with cT3a PCa with the aim to help guide treatment decisions in clinical practice. Design, setting, and participants: This was a multicenter retrospective cohort study including 759 consecutive patients with cT3a PCa treated with RP between 1987 and 2010. Intervention: Retropubic RP and pelvic lymphadenectomy. Outcome measurements and statistical analysis: Patients were divided into pretreatment prostate-specific antigen (PSA) and biopsy Gleason score (GS) subgroups. These parameters were used to construct tables predicting pathologic outcome and the presence of positive lymph nodes (LNs) after RP for cT3a PCa using ordinal logistic regression…(ver más)